Malin L Hultcrantz

56PUBLICATIONS
216CO-AUTHORS
Haematological tumoursMedical bacteriologyMedical mycologyGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Jul 29, 2026
Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.

|Jul 20, 2026
Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool.

|Jul 14, 2026
Clinical and Psychological Outcomes After Monoclonal Gammopathy Screening: A Population-Based Screening Study and Subsequent Randomized Trial of Follow-Up.

|Jun 12, 2026
Genomic features do not account for differences in multiple myeloma risk by ancestry.

|May 01, 2026
A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients.

|Apr 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.

Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve

Pageof 10

Frequent Collaborators

35 joint publications

Kylee Maclachlan

32 joint publications

Urvi Shah

26 joint publications

Ola Landgren

26 joint publications

Sergio Giralt